Annual CFO
-$45.68 M
-$15.88 M-53.26%
31 December 2023
Summary:
CG Oncology Common stock annual cash flow from operations is currently -$45.68 million, with the most recent change of -$15.88 million (-53.26%) on 31 December 2023. CGON annual CFO is now -234.55% below its all-time high of -$13.65 million, reached on 01 December 2021.CGON Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFO
-$15.92 M
+$201.00 K+1.25%
30 September 2024
Summary:
CG Oncology Common stock quarterly cash flow from operations is currently -$15.92 million, with the most recent change of +$201.00 thousand (+1.25%) on 30 September 2024. Over the past year, it has dropped by -$3.66 million (-29.82%). CGON quarterly CFO is now -99.34% below its all-time high of -$7.99 million, reached on 31 March 2023.CGON Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFO
-$72.70 M
-$3.66 M-5.30%
30 September 2024
Summary:
CG Oncology Common stock TTM cash flow from operations is currently -$72.70 million, with the most recent change of -$3.66 million (-5.30%) on 30 September 2024. Over the past year, it has dropped by -$41.66 million (-134.25%). CGON TTM CFO is now -810.29% below its all-time high of -$7.99 million, reached on 31 March 2023.CGON TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CGON Cash From Operations Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -53.3% | -29.8% | -134.3% |
| 3 y3 years | - | - | - |
| 5 y5 years | - | - | - |
CGON Cash From Operations High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -234.6% | at low | -99.3% | +38.8% | -810.3% | at low |
| 5 y | 5 years | -234.6% | at low | -99.3% | +38.8% | -810.3% | at low |
| alltime | all time | -234.6% | at low | -99.3% | +38.8% | -810.3% | at low |
CG Oncology Common Stock Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$15.92 M(-1.2%) | -$72.70 M(+5.3%) |
| June 2024 | - | -$16.12 M(-38.0%) | -$69.04 M(+8.4%) |
| Mar 2024 | - | -$26.01 M(+77.6%) | -$63.70 M(+39.5%) |
| Dec 2023 | -$45.68 M | -$14.64 M(+19.4%) | -$45.68 M(+47.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2023 | - | -$12.26 M(+13.7%) | -$31.03 M(+65.3%) |
| June 2023 | - | -$10.79 M(+35.1%) | -$18.77 M(+135.1%) |
| Mar 2023 | - | -$7.99 M | -$7.99 M |
| Dec 2022 | -$29.80 M(+118.3%) | - | - |
| Dec 2021 | -$13.65 M | - | - |
FAQ
- What is CG Oncology Common stock annual cash flow from operations?
- What is the all time high annual CFO for CG Oncology Common stock?
- What is CG Oncology Common stock annual CFO year-on-year change?
- What is CG Oncology Common stock quarterly cash flow from operations?
- What is the all time high quarterly CFO for CG Oncology Common stock?
- What is CG Oncology Common stock quarterly CFO year-on-year change?
- What is CG Oncology Common stock TTM cash flow from operations?
- What is the all time high TTM CFO for CG Oncology Common stock?
- What is CG Oncology Common stock TTM CFO year-on-year change?
What is CG Oncology Common stock annual cash flow from operations?
The current annual CFO of CGON is -$45.68 M
What is the all time high annual CFO for CG Oncology Common stock?
CG Oncology Common stock all-time high annual cash flow from operations is -$13.65 M
What is CG Oncology Common stock annual CFO year-on-year change?
Over the past year, CGON annual cash flow from operations has changed by -$15.88 M (-53.26%)
What is CG Oncology Common stock quarterly cash flow from operations?
The current quarterly CFO of CGON is -$15.92 M
What is the all time high quarterly CFO for CG Oncology Common stock?
CG Oncology Common stock all-time high quarterly cash flow from operations is -$7.99 M
What is CG Oncology Common stock quarterly CFO year-on-year change?
Over the past year, CGON quarterly cash flow from operations has changed by -$3.66 M (-29.82%)
What is CG Oncology Common stock TTM cash flow from operations?
The current TTM CFO of CGON is -$72.70 M
What is the all time high TTM CFO for CG Oncology Common stock?
CG Oncology Common stock all-time high TTM cash flow from operations is -$7.99 M
What is CG Oncology Common stock TTM CFO year-on-year change?
Over the past year, CGON TTM cash flow from operations has changed by -$41.66 M (-134.25%)